Reversing EGFR Mediated Immunoescape by Targeted Monoclonal Antibody Therapy
Uncontrolled growth is a signature of carcinogenesis, in part mediated by overexpression or overstimulation of growth factor receptors. The epidermal growth factor receptor (EGFR) mediates activation of multiple oncogenic signaling pathways and escape from recognition by the host immune system. We d...
Saved in:
Main Authors: | Fernando Concha-Benavente (Author), Robert L. Ferris (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients
by: Zaima Mazorra, et al.
Published: (2017) -
EGFR FISH analysis in colorectal cancer as a tool in selecting patients for antiEGFR monoclonal antibodies therapy
by: Mauro Moroni, et al.
Published: (2011) -
Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer
by: Nasrul Wathoni, et al.
Published: (2022) -
Monoclonal Antibody-Directed Therapy
Published: (2022) -
Monoclonal Antibody Therapy in Alzheimer's Disease
by: Monica Neațu, et al.
Published: (2023)